Oscar Health, Inc. $OSCR Shares Sold by Ardsley Advisory Partners LP

Key Points

• Ardsley Advisory Partners LP significantly reduced its stake in Oscar Health, cutting its holdings by 68.9% to 350,000 shares after selling 775,000 shares during the first quarter.
• Several brokerages have downgraded Oscar Health's stock, with Barclays reducing its target price from $17.00 to $11.00 and Wells Fargo lowering it from $16.00 to $10.00.
• Oscar Health reported a negative EPS of ($0.89) for the last quarter, beating estimates slightly, while its revenue increased by 29.0% year-over-year, reaching $2.86 billion.

Ardsley Advisory Partners LP decreased its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 68.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 350,000 shares of the company's stock after selling 775,000 shares during the period. Ardsley Advisory Partners LP owned about 0.14% of Oscar Health worth $4,588,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Oscar Health by 3.7% in the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after purchasing an additional 700,469 shares during the last quarter. Deerfield Management Company L.P. Series C grew its holdings in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its holdings in Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after purchasing an additional 467,301 shares during the last quarter. Thrive Capital Management LLC grew its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Finally, BIT Capital GmbH grew its holdings in shares of Oscar Health by 1.1% during the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after buying an additional 47,592 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of OSCR stock traded up $1.03 during mid-day trading on Friday, hitting $19.41. 16,354,315 shares of the stock were exchanged, compared to its average volume of 16,577,883. The firm has a fifty day moving average of $15.78 and a 200 day moving average of $15.00. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a market cap of $5.02 billion, a PE ratio of -23.96 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the prior year, the company posted $0.20 EPS. The company's revenue for the quarter was up 29.0% on a year-over-year basis. Research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of research analyst reports. Baird R W lowered shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Wells Fargo & Company lowered shares of Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $16.00 to $10.00 in a report on Friday, July 11th. Wall Street Zen lowered shares of Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, UBS Group restated a "sell" rating and set a $11.00 target price (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Four research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, Oscar Health presently has a consensus rating of "Strong Sell" and an average target price of $12.07.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.